Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis.
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 2b, Multi-national, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Followed by a Long-term Extension to Evaluate the Efficacy and Safety of SAR442970 in Adult Participants With Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-23The Effect of VSL#3 (Original De Simone Formulation) Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
-
CLINICAL_TRIALS study record update · 2026-04-21Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-20Colonoscopic Investigation of the Correlation Between Bowel Wall Inflammation and Luminal Temperature Rise in IBD
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
-
CLINICAL_TRIALS study record update · 2026-04-20An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination With Mirikizumab for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 2, Multicenter, Randomized, Double-Blind, Active-Controlled Study of LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-04-17A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the Long-term Efficacy and Safety of Mirikizumab in Children and Adolescents With Moderate-to-severe Ulcerative Colitis or Crohn's Disease
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase IB/IIA Study of Remestemcel-L, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cell Product, for the Treatment of Medically Refractory Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease
-
CLINICAL_TRIALS study record update · 2026-04-16Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)
-
CLINICAL_TRIALS study record update · 2026-04-15Prospective Study of the Natural History, Immunological and Genetic Characteristics of Preclinical Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-04-15Fecal Microbiome Transplant in Pediatric C. Difficile
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Induction Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2026-04-13Describing Prescription Patterns in an Ulcerative Colitis Population and Generating an Updated Ulcerative Colitis Treatment Paradigm
-
CLINICAL_TRIALS study record update · 2026-04-13Prospective Observational Study Of Naturopathic Approaches To IBS
-
CLINICAL_TRIALS study record update · 2026-04-13A Prospective, Real-World Study Evaluating the Impact of RISankizumab on BurdEn of Disease in Ulcerative Colitis in JaPan (RISE UP)
-
CLINICAL_TRIALS study record update · 2026-04-13A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)